Navigation Links
Leading researchers and experts gather to discuss latest advancements in drug discovery
Date:1/8/2008

WHO: Society for Biomolecular Sciences (SBS)

WHAT: Latest Findings and Research on Advancements in Drug Discovery and Biotechnology

WHEN: April 6-10, 2008

WHERE: SBS 14th Annual Conference at Americas Center, St. Louis, Missouri

BACKGROUND:

More than 2,500 researchers and professionals in the area of biomolecular science and drug discovery are expected to attend the 14th Annual Conference & Exhibition of the Society for Biomolecular Sciences to discuss advances in biotechnology, challenges and automation solutions in the field. Topics and speakers scheduled for the St. Louis meeting this year include:

  • Methods in phenotypic and mechanistic screening for primary cells and stem cells in drug discovery

  • Latest techniques in targeting the appropriate genes in the human genome sequence to identify novel mechanisms for human disease treatment

  • Development of small molecule anti-cancer agents

  • Label-free detection in high-throughput screening and lead validation

SPECIAL GUEST SPEAKERS:

  • Jonathan D. Gitlin, M.D., Helene B. Roberson Professor of Pediatrics and professor of genetics, Washington University School of Medicine; scientific director of the Childrens Discovery Institute, who will address: Child Health Research in the 21st Century: Obstacles and Opportunities

  • Janet Woodcock, M.D., deputy commissioner, U.S. Food & Drug Administration, who will address: The Promise of Molecular Medicine

  • Jeffrey I. Gordon, M.D., Dr. Robert J. Glaser Distinguished University Professor, Washington University School of Medicine, who will address: Dining in With a Few Trillion Friends: Exploring the Human Gut Microbiota and Microbiome

The meeting will also offer sessions on translational medicine, biomarkers and discovery, and the development of vaccines and monoclonal antibodies.


'/>"/>

Contact: Jennifer Bender
jbender@environics-usa.com
203-325-8772 x17
Society for Biomolecular Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology
2. Leading experts cite poor health and nutrition as major barrier to education in developing world
3. Ossur -- leading orthopedic pioneer - expands network to Asia
4. Leading researchers to reveal comprehensive dos and donts for prostate cancer
5. BIO-key(R) PocketCop(R) Project Leading the Nation According to Televised Report
6. Are current projections of climate change-impacts on biodiversity misleading?
7. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
8. Leading cause of death in preemies might be controlled by resetting a molecular switch
9. Researchers identify proteins involved in new neurodegenerative syndrome
10. Texas researchers and educators head for Antarctica
11. MGH researchers describe new way to identify, evolve novel enzymes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: